In a very current study, we claimed the identification as well as the characterization of a new atypical opioid receptor with special adverse regulatory properties toward opioid peptides.1 Our outcomes confirmed that ACKR3/CXCR7, hitherto often known as an atypical scavenger receptor for chemokines CXCL12 and CXCL11, is also a https://yehudak258qmh7.newsbloger.com/profile